Get the Stockscreener App
1.83
1.95%
0.035
Biomea Fusion Inc stock is traded at $1.83, with a volume of 343.61K.
It is up +1.95% in the last 24 hours and up +0.55% over the past month.
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.
See More
Previous Close:
$1.795
Open:
$1.8
24h Volume:
343.61K
Relative Volume:
0.15
Market Cap:
$108.90M
Revenue:
-
Net Income/Loss:
$-144.01M
P/E Ratio:
-0.4564
EPS:
-4.01
Net Cash Flow:
$-113.02M
1W Performance:
+5.78%
1M Performance:
+0.55%
6M Performance:
-47.11%
1Y Performance:
-73.38%
1-Day Range:
$1.7737
$1.85
1-Week Range:
$1.69
$1.86
52-Week Range:
$1.2905
$13.07
Biomea Fusion Inc Stock (BMEA) Company Profile
Name
Biomea Fusion Inc
Sector
Industry
Phone
(650) 980-9099
Address
1599 INDUSTRIAL ROAD, SAN CARLOS
Compare BMEA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.83 | 103.54M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Resumed | Piper Sandler | Overweight |
| Oct-09-24 | Initiated | Edward Jones | Buy |
| Sep-27-24 | Upgrade | Rodman & Renshaw | Neutral → Buy |
| Sep-27-24 | Upgrade | Truist | Hold → Buy |
| Aug-29-24 | Initiated | CapitalOne | Overweight |
| Jun-11-24 | Downgrade | Truist | Buy → Hold |
| Jun-07-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-06-24 | Initiated | Truist | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Jun-26-23 | Downgrade | Jefferies | Buy → Hold |
| May-12-23 | Initiated | Barclays | Overweight |
| Mar-29-23 | Reiterated | Oppenheimer | Outperform |
| Mar-28-23 | Reiterated | H.C. Wainwright | Buy |
| Feb-24-23 | Initiated | Citigroup | Buy |
| Jun-02-22 | Resumed | H.C. Wainwright | Buy |
| Jan-12-22 | Initiated | H.C. Wainwright | Buy |
| Dec-17-21 | Initiated | Oppenheimer | Outperform |
| May-11-21 | Initiated | JP Morgan | Overweight |
| May-11-21 | Initiated | Jefferies | Buy |
| May-11-21 | Initiated | Piper Sandler | Overweight |
View All
Biomea Fusion Inc Stock (BMEA) Latest News
Will Biomea Fusion Inc. stock hit new highs in YEARTrend Reversal & Growth-Oriented Investment Plans - newsimpact.co.kr
Fibonacci Levels Suggest Recovery for Biomea Fusion Inc.July 2025 Catalysts & High Yield Equity Trading Tips - beatles.ru
Blue Owl Capital Holdings LP Acquires 3,800,000 Shares in Biomea Fusion Inc: A Strategic Investment in the Biotechnology Sector - AInvest
Blue Owl Capital Holdings LP Acquires 3,800,000 Shares in Biomea Fusion Inc - GuruFocus
Certain Stock Options of Biomea Fusion, Inc. are subject to a Lock-Up Agreement Ending on 17-AUG-2025. - MarketScreener
Certain Common Stock of Biomea Fusion, Inc. are subject to a Lock-Up Agreement Ending on 17-AUG-2025. - MarketScreener
What makes Biomea Fusion Inc. stock price move sharplyWeekly Stock Report & Low Drawdown Investment Ideas - thegnnews.com
Biomea Fusion Faces Big Swings While Chasing Diabetes Breakthroughs - Finimize
Published on: 2025-08-16 07:07:16 - Newser
Why Biomea Fusion Inc. stock attracts strong analyst attentionMarket Volume Report & Long Hold Capital Preservation Tips - Newser
Volatility clustering patterns for Biomea Fusion Inc.Dollar Strength & Consistent Return Investment Signals - Newser
Quantitative breakdown of Biomea Fusion Inc. recent movePortfolio Performance Summary & Safe Entry Trade Signal Reports - Newser
Real time alert setup for Biomea Fusion Inc. performanceJuly 2025 Highlights & Real-Time Buy Signal Notifications - Newser
Biomea Fusion Inc. Sees Spike in Bullish Option FlowWeekly Stock Analysis & Community Verified Trade Alerts - newsimpact.co.kr
How Biomea Fusion Inc. stock performs during market volatilityWeekly Trade Analysis & Free Expert Approved Momentum Trade Ideas - Newser
Biomea Fusion's Cash Burn: Is Growth Afforded? - AInvest
Can Biomea Fusion (NASDAQ:BMEA) Afford To Invest In Growth? - Yahoo Finance
Biomea Fusion files $300M mixed securities shelf - MSN
Is Biomea Fusion Inc. in a bullish channelInsider Buying & Free Safe Entry Trade Signal Reports - sundaytimes.kr
Published on: 2025-08-14 01:49:08 - Newser
Citigroup Has Lowered Expectations for Biomea Fusion (NASDAQ:BMEA) Stock Price - Defense World
Citigroup lowers Biomea Fusion PT to $7 from $9, maintains Buy rating. - AInvest
Biomea Fusion: Promising Trials and Strategic Innovations Drive Buy Rating - TipRanks
Biomea Fusion's Price Target Lowered to $7, Maintaining Buy Rating Despite Recent Share Dilution. - AInvest
Price Consolidation Hints at Upcoming Move in Biomea Fusion Inc.Growth Based Stock Signal Screener Updated - metal.it
Biomea Fusion (BMEA) Q2 Loss Drops 44% - AOL.com
HC Wainwright Raises Earnings Estimates for Biomea Fusion - Defense World
Biomea Fusion (NASDAQ:BMEA) Earns Buy Rating from D. Boral Capital - Defense World
Scotiabank Issues Pessimistic Forecast for Biomea Fusion (NASDAQ:BMEA) Stock Price - Defense World
How sensitive is Biomea Fusion Inc. to inflationTop 100 Low Volatility Gainers - sisaissue.com
Scotiabank Maintains Biomea Fusion(BMEA.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
Biomea Fusion Trims Losses As Investors Hold Out Hope - Finimize
Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights - The Manila Times
Biomea Fusion Reports Q2 2025 Financial Results - TipRanks
Biomea Fusion (BMEA) Q2 Loss Drops 44% - The Motley Fool
Biomea Fusion Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biomea Fusion Q2 net loss narrows to $20.7 mln - MarketScreener
Biomea Fusion's $300M Shelf Filing: A Strategic Play in a High-Stakes Biotech Market - AInvest
Biomea Fusion files $300M mixed-securities shelf - AInvest
RENEW 8-K: Ninth SPAC Extension Adds $250k to Trust, Deadline Sep 5 2025 | BMEA SEC FilingForm 8-K - Stock Titan
Biomea's Diabetes Drug Shows Lasting Effects, New Obesity Treatment Achieves 15% Weight Loss in Primates - Stock Titan
How volatile is Biomea Fusion Inc. stock compared to the marketDiscover undervalued opportunities early - Jammu Links News
What are analysts’ price targets for Biomea Fusion Inc. in the next 12 monthsFree Stock Chart Pattern Guide - Jammu Links News
Biomea Fusion Inc. Stock Analysis and ForecastUnstoppable investment returns - Jammu Links News
Is Biomea Fusion Inc. a growth stock or a value stockUnlock your portfolio’s hidden potential - Jammu Links News
What is the risk reward ratio of investing in Biomea Fusion Inc. stockBuild wealth with high-performing stocks - Jammu Links News
What markets is Biomea Fusion Inc. expanding into Is MAMO stock a good long term investment option - Jammu Links News
Should I hold or sell Biomea Fusion Inc. stock in 2025Rapidly growing investment returns - Jammu Links News
What is the dividend policy of Biomea Fusion Inc. stockAchieve consistent profits with proven strategies - Jammu Links News
Is it the right time to buy Biomea Fusion Inc. stockBuild a winning investment strategy today - Jammu Links News
What analysts say about Biomea Fusion Inc. stockAchieve rapid portfolio growth with smart picks - Jammu Links News
Biomea Fusion Inc Stock (BMEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):